Showing results 1 to 20 of 173
next >
| Issue Date | Title | Author(s) |
| 2022-01-12 | Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. | Hemrajani, C; Negi, P; Parashar, A; Gupta, G; Jha, NK; Singh, SK; Chellappan, DK; Dua, K |
| 2022-01-10 | Studies on Synthesis and Characterization of Fe3O4@SiO2@Ru Hybrid Magnetic Composites for Reusable Photocatalytic Application | Kumar, AP; Bilehal, D; Desalegn, T; Kumar, S; Ahmed, F; Murthy, HCA; Kumar, D; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Lee, Y-I |
| 2021-12 | Natural products in the management of obesity: Fundamental mechanisms and pharmacotherapy | Chan, Y; Ng, SW; Tan, JZX; Gupta, G; Negi, P; Thangavelu, L; Balusamy, SR; Perumalsamy, H; Yap, WH; Singh, SK; Caruso, V; Dua, K; Chellappan, DK |
| 2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
| 2021-12 | Development and validation of RP-HPLC based bioanalytical method for simultaneous estimation of curcumin and quercetin in rat's plasma | Wadhwa, S; Kumar, B; Gulati, M; Gupta, S; Chaitanya, MVNL; Kumar, D; Jha, NK; Gupta, G; Prasher, P; Chellappan, DK; Dua, K; Singh, SK |
| 2021-10-15 | Protein and peptide delivery to lungs by using advanced targeted drug delivery. | Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K |
| 2021-09-13 | A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations. | Joshi, D; Sharma, I; Gupta, S; Singh, TG; Dhiman, S; Prashar, A; Gulati, M; Kumar, B; Vishwas, S; Chellappan, DK; Gupta, G; Jha, NK; Gupta, PK; Negi, P; Dua, K; Singh, SK |
| 2021-09 | Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective | Chan, Y; Ng, SW; Singh, SK; Gulati, M; Gupta, G; Chaudhary, SK; Hing, GB; Collet, T; MacLoughlin, R; Löbenberg, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2021-09 | Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: A Hypothesis | Kaur, J; Gulati, M; Gowthamarajan, K; Vishwas, S; Kumar Chellappan, D; Gupta, G; Dua, K; Pandey, NK; Kumar, B; Singh, SK |
| 2021-08 | A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics | Anand, K; Vadivalagan, C; Joseph, JS; Singh, SK; Gulati, M; Shahbaaz, M; Abdellattif, MH; Prasher, P; Gupta, G; Chellappan, DK; Dua, K |
| 2021-08 | Overview of key molecular and pharmacological targets for diabetes and associated diseases | Shahcheraghi, SH; Aljabali, AAA; Al Zoubi, MS; Mishra, V; Charbe, NB; Haggag, YA; Shrivastava, G; Almutary, AG; Alnuqaydan, AM; Barh, D; Dua, K; Chellappan, DK; Gupta, G; Lotfi, M; Serrano-Aroca, Á; Bahar, B; Mishra, YK; Takayama, K; Panda, PK; Bakshi, HA; Tambuwala, MM |
| 2021-08 | Development of mushroom polysaccharide and probiotics based solid self-nanoemulsifying drug delivery system loaded with curcumin and quercetin to improve their dissolution rate and permeability: State of the art | Khursheed, R; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Jain, SK; Gowthamarajan, K; Zacconi, F; Chellappan, DK; Gupta, G; Jha, NK; Gupta, PK; Dua, K |
| 2021-07-01 | Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19 | Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK |
| 2021-07-01 | CRISPR-Cas9 gene editing: New hope for Alzheimer's disease therapeutics | Bhardwaj, S; Kesari, KK; Rachamalla, M; Mani, S; Ashraf, GM; Jha, SK; Kumar, P; Ambasta, RK; Dureja, H; Devkota, HP; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Ruokolainen, J; Kamal, MA; Ojha, S; Jha, NK |
| 2021-07 | Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies | Alnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK |
| 2021-06 | Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome | Corrie, L; Gulati, M; Singh, SK; Kapoor, B; Khursheed, R; Awasthi, A; Vishwas, S; Chellappan, DK; Gupta, G; Jha, NK; Anand, K; Dua, K |
| 2021-06 | Nuclear factor-kappa B and its role in inflammatory lung disease | Alharbi, KS; Fuloria, NK; Fuloria, S; Rahman, SB; Al-Malki, WH; Javed Shaikh, MA; Thangavelu, L; Singh, SK; Rama Raju, VS; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2021-06 | Current trends on resveratrol bioactivities to treat periodontitis | Sharifi-Rad, J; Quispe, C; Alfred, MA; Anil Kumar, NV; Lombardi, N; Cinquanta, L; Iriti, M; Varoni, EM; Gupta, G; Chellappan, DK; Dua, K; Cardoso, SM; Peron, G; Dey, A; Cruz-Martins, N; Rodrigues, CF |
| 2021-05-29 | Medicinal Plants for Lung Diseases A Pharmacological and Immunological Perspective | Dua, K; Nammi, S; Chang, D; Chellappan, DK; Gupta, G; Collet, T |
| 2021-05-29 | Medicinal Plants for Lung Diseases A Pharmacological and Immunological Perspective | Dua, K; Nammi, S; Chang, D; Chellappan, DK; Gupta, G; Collet, T |
